Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001123292-21-000084
Filing Date
2021-01-19
Accepted
2021-01-19 17:19:29
Documents
2
Period of Report
2021-01-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1751
2 EXHIBIT 24 - POWER OF ATTORNEY hmpoa2.htm EX-24 7974
  Complete submission text file 0001123292-21-000084.txt   11096
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Issuer) CIK: 0001661059 (see all company filings)

EIN.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEXTCURE, INC. 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address
Myint Han (Reporting) CIK: 0001840942 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38905 | Film No.: 21536367